Ewg Elevate Inc. Madrigal Pharmaceuticals, Inc. Transaction History

Ewg Elevate Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 10, 2023	BUY	$58.39 - $296.54 $29,195 - $148,270	500 New	500 $0
Q2 2020 Jul 07, 2020	SELL	$60.13 - $125.71 $666,601 - $1.39 Million	-11,086 Closed	0 $0
Q1 2020 Apr 15, 2020	BUY	$66.76 - $93.49 $258,761 - $362,367	3,876 Added 53.76%	11,086 $740,000
Q4 2019 Jan 28, 2020	BUY	$84.28 - $118.5 $607,658 - $854,385	7,210 New	7,210 $657,000

298

22M

819K

640K

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.17B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

Get notified when there are updates to the investment portfolio of Ewg Elevate Inc., based on Form 13F filings with the SEC.

Stay updated on Ewg Elevate Inc. with notifications on news.